OPP Meeting Summary: EP ENVI Committee – Exchange of Views with Commissioner Kyriakides (18 February 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Speech by Commissioner Kyriakides: Bigger than Life – Rare Disease Day 2020

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: EP ENVI Committee Meeting (17 & 18 February 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Webinar on the role of the European Medicines Agency (26 February 2020)

Lung Cancer Europe (LuCE) is holding a webinar on the role of the European Medicines Agency (EMA) and how patients and patient advocates can be involved in the drug approval process.

The webinar is intended for an audience of advocates, patients and caregivers. It will be given by Kate Morgan, Head of Policy and Access of Myeloma Patients Europe (MPE).

Press Release: European Investment Bank provides funding of €40 million to ITM

The European Investment Bank (EIB) provides €40 million to ITM Isotopen Technologien München AG (ITM), a company dedicated to the development, production and global supply of innovative diagnostic and therapeutic radiopharmaceuticals for use in Precision Oncology. ITM will use the fresh funds for investments in research and development of a proprietary portfolio of Targeted Radionuclide Diagnostics and Therapies, addressing a range of cancers such as neuroendocrine tumours and bone metastases.

UPDATED – EMA Paediatric Committee (PDCO)(17-20 September 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Event: EP ENVI Committee Workshop on Cancer prevention – Modifiable risk factors (Brussels, 18 February 2020)

Europe’s Beating Cancer Plan is expected by the end of the year, and preparatory work and consultations are currently ongoing to shape the plan, set priorities and outline future action. This workshop looks into one of the key topics, modifiable risk factors and cancer prevention. Experts from all across the cancer spectrum will discuss with MEPs the state of play and main challenges, with a special angle on paediatric, digestive and HPV cancers.

Question for a Written Answer: Air pollution from wood burning

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Event: Lisbon Addictions 2019 (Lisbon, 23-25 October 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Targeted Consultation for CLH Proposals

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

‘Treating cancer is only part of the journey’: the overlooked needs of cancer survivors

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

European Commission launches EU-wide public consultation on Europe’s Beating Cancer Plan

Today, on World Cancer Day, the European Commission is launching an EU-wide public consultation on Europe’s Beating Cancer Plan. The consultation will help shape the Plan, identify key areas, and explore future action.

UPDATED – Agenda: 1st Meeting of the Mission Board for Cancer (3 September 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Roadmap: Europe’s Beating Cancer Plan

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

OPP Meeting Summary: EP ENVI Committee – Objection pursuant to Rule 112 on plant protection products (3 February 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Stakeholder Publication: Lung Cancer Europe: 2020 Position Paper – Disparities and challenges in access to lung cancer diagnosis and treatment across Europe

By Lung Cancer Europe

Lung cancer is responsible for nearly 1 in 5 cancer related deaths in Europe, yet it remains a cancer that is underfunded and underrepresented. Previous research has demonstrated that many people impacted by lung cancer face disparities in access to diagnostics, treatment and care.

To mark World Cancer Day, LuCE has released its latest position paper which identifies disparities and challenges in access to lung cancer diagnostics and treatment across Europe. Data were collected through 34 healthcare professionals/researchers, 16 pharmaceutical companies and LuCE members (patient organizations).

A European master plan to fight cancer

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. Cookies help you create your Policy Newsfeed for example. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close